CHRS earnings call for the period ending June 30, 2019.
News & Analysis: Coherus BioSciences
Bad news on multiple fronts hit stocks.
The business reported an upbeat update, but something got lost in translation on Wall Street.
CHRS earnings call for the period ending March 31, 2019.
Guess which of these stocks could see big changes ahead.
The biosimilar leader announced preliminary sales data for its most important product.
CHRS earnings call for the period ending December 31, 2018.
The company secured a deal paving the way to commercialize a generic version of the former best-selling drug in the world.
Enthusiasm for the biopharma is wearing off despite its announcement of an important commercial milestone.
The biosimilar developer received some good news from a regulator.